Reversal of the sleep/wake cycle disorder of sleeping sickness after trypanosomicide treatment

Journal of Sleep Research

Volumn 8, Issue 3, 1999, Pages 225-235

  Buguet, Alain ^a,c   Tapie, Philippe ^b   Bert, Jacques ^b  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b UNIVERSITÉ DE LIMOGES   (France)

^c CENTRE DE RECHERCHES   (France)

Author keywords

Circadian rhythms; Melarsoprol; Sleep; Sleeping sickness; SOREMP

Indexed keywords

MELARSOPROL;

ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; CLINICAL ARTICLE; DEVICE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROOCULOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONREM SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP WAKING CYCLE; TRYPANOSOMA;

ADULT; CIRCADIAN RHYTHM; CONGO; ELECTROOCULOGRAPHY; FEMALE; HUMANS; MALE; MELARSOPROL; MIDDLE AGED; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX; SLEEP, REM; TIME FACTORS; TREATMENT OUTCOME; TRYPANOCIDAL AGENTS; TRYPANOSOMIASIS, AFRICAN; WAKEFULNESS;

EID: 0032884014     PISSN: 09621105     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2869.1999.00160.x     Document Type: Article

References (27)

1. Abdi, Y. A., Gustafsson, L. L., Ericsson, O. and Hellgren, U. (Eds) Melarsoprol., Handbook of Drugs for Tropical Parasitic Infections. Taxtor and Francis, London. 1995: 89-94.
2. Adam, K. Sleep is changed by blood sampling through an indwelling venous catheter, Sleep. 1982, 5: 154-158.
3. Bert, J. Collomb, H., Fressv, J. and Gastaud, H. Etude electroercénbalographique du sommeil nocturne au cours de la trypar osomase humaine africaine. In H. Fischgold (Ed.) Le Sammai de Nuit Normal et Pathologique. Etudes Electroencephalographiques. Masson, Paris, 1965: 334-352.
4. Brandenberger, G., Buguet, A., Spiegel, K., Stanghellim, A., Muanga, G., Bogin, P. and Dumas, M. Disruption of endocrine rhythms in steeping sickness with preserved relationship between hormonalpulsat lite and the REM-NREM sleep cycles. J. Biol. Rhythms, 1996, 11: 253-267.
5. Buguet, A. Cireadian disorders in sleeping sickness. Neurol. Intect. Epidemiol., 1997, 2: 39-47.
6. Buguet, A., Bert J., Tapie, P., Tabaraud, F., Doua, L., Lonsdorfer, J., Boem P. and Dumas, M. Sleep-wake cycle in human African trypanonomiasis J. Clin. Neurophysiol. 1993. 10: 190-196.
7. Buguet, A Gati, R., Sèvre, J. P., Doveloux, M., Bogui, P. and Lonsdorfer. J. 24 hour polysomnographic evaluation in a patient with sleeping sickness. Electroenceph. Clin. Neurophysiol., 1989, 72: 471-473.
8. Buguet, A., Rivolter, J and Jouvet, M. Human sleep patterns in Antarchet. Sleep. 1987, 10: 374-382.
9. Claustrat, B. Buguet, A., Geoffriau, M., Bogui, P., Mouanga, G., Stangheilmi, A. and Dumas, M. Plasma melatonin rhythm is maintained in human African trynanosomiasis. Neuroendocrinology, 1998, 68: 64-70.
10. Doua, F. and Boa, F. Y. Actualités thérapeutiques de la trypanosomiase, Bull. Soc. Pathol. Ex., 1994, 87: 337-340.
11. Dumas, M. and Boa, F. Y. Human African trypanosomiasis. In: A. A Harris (Ed.) Handbook of Clinical Neurology. Elsevier Science Publishers, Amsterdam, 1988: 339-344.
12. Friedman, E. A. H. Mel B in the treatment of human trypanosomiasis. Am. J. Trop. Med. Hyg., 1949, 29: 173-180.
13. Gati, R., Tabaraud, F., Buguet, A., Bert, J., Tapie, P., Bittel, J., Sparkes, B., Breton, J. C., Doua, F., Bogui, P., Lonsdorfer, A., Lonsdorfer, J., Moulin, J., Chameaud, J. and Dumas, M. Analyse circadienne du sommeil, de la température rectale et de variables immunologiques et endocrinologiques dans la maladie du sommeil: étude préliminaire. Bull. Soc. Puthol. Ex., 1990, 83: 275-282.
14. Haller, L., Adams, H., Mérouze, F. and Dago, A. Clinical and pathological aspects of human African trypanosomiasis (T. gambiense) with particular reference to reactive arsenical encephalopathy. Am. J. Trop. Med. Hyg., 1986, 35: 94-99.
15. Henderson, G. B. and Fairlamb, A. H. Trypanothione metabolism: a chemotherapeutic target in trypanosomatids. Parasitol. Today, 1987, 3: 312-315.
16. Krauth-Siegel, B. L. and Schöneck, R. Trypanothione reductase and lipoamide dehydrogenase as targets for a structure-based drug design. FASEB J., 1995, 9: 1138-1146.
17. Manson-Bahr, P. Mansons Tropical Diseases. A Manual of Diseases of Warm Climates. Cassel, London, 1942.
18. Montmayeur, A., Brosset, C., Imbert, P. and Buguet, A. Cycle veillesommeil au décours d'une trypanosomose humaine africaine à Trypanosoma brucei rhodesiense chez deux parachutistes français. Bull. Soc. Pathol. Ex., 1994, 87: 368-371.
19. Mouret, J., Lemoine, P., Minuit, M. P. and Robclin, N. La L-tyrosine guérit immédiatement et à long terme les dépressions dopamino-dépendantes (DDD). Etude clinique et polygraphique. C. R. Acad. Sci. (Paris), 1988, 306: 93-98.
20. Pepin, J. and Milord, F. The treatment of human African trypanosomiasis. Adv. Parasitol., 1994, 33: 1-47.
21. Radomski, M. W., Buguet, A., Doua, F., Bogui, P. and Tapie, P. Relationship of plasma growth hormone to slow-wave sleep in African sleeping sickness. Neuroendocrinology, 1996, 63: 393-396.
22. Radomski, M. W., Buguet, A., Montmayeur, A., Bogui, P., Bourdon, L., Doua, F., Lonsdorfer, A., Tapie, P. and Dumas, M. 24-hour plasma cortisol and prolactin in human African trypanosomiasis patients and healthy African controls. Am. J. Trop. Med. Hyg., 1995, 52: 281-286.
23. Rechtschaffen, A. and Kales, A. A Mannual of Standardized Terminology, Techniques and Scoring System for Sleep Stagey of Human Subjects. Public Health Service. U-S. Govt. P.O., Washington D.C., 1968.
24. Robertsson, D. H. H. The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. I. Reactions observed during treatment. Trans. R. Soc. Trop. Med. Hyg., 1963, 57: 1246-1250.
25. Schwartz, B. A. and Escande, C. Sleeping sickness: sleep study of a case. Electroenceph. Clin. Neurophysiol., 1970, 29: 83-87.
26. Van Nieuwenhove, S. Present strategies in the treatment of human African trypanosomiasis. In: M. Dumas, B. Bouteille and A. Buguet (Eds) Progress in Human African Trypanosomiasis, Sleeping Sickness. Springer Verlag, Paris, 1999, 253-280.
27. Wang, C. C. Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis. Annu. Rev. Pharmacol. Toxicol., 1995, 35: 93-127.